The Karimi Lab has two open CIHR-Funded positions for graduate students. Our team is a highly productive and internationally recognized group for its contributions to therapeutic development for spinal cord injury and multiple sclerosis. We also study disease mechanisms using relevant transgenic models and primary in vitro systems. We are located at the Regenerative Medicine Program and Department of Physiology at the University of Manitoba in Winnipeg.
The Karimi program works at the forefront of regenerative neuroscience and provides an excellent environment for training the next generation of neuroscientists. Our research focuses on promoting neural repair and regeneration after injuries to the central nervous system with special interest in spinal cord injury (SCI) and multiple sclerosis (MS). We use stem cell-based, pharmacological and bioengineered therapeutic approaches in preclinical models of SCI and MS. We specifically focus on developing repair strategies to modulate neuroinflammation and optimize white matter repair by promoting the replacement of oligodendrocyte, axonal protection and remyelination. Our lab is well-equipped with advanced technologies in neuroscience and stem cell research that include in vivo micro-surgical techniques, transgenic models, stem cell/neural tissue culture, pharmacological drug delivery, cellular, biochemical and molecular techniques, genetic manipulations, fluorescence/confocal imaging, bioengineering approaches, live animal imaging and functional/neurological analyses. Our research has high translational implications.
The Karimi laboratory is located within the state-of-art Regenerative Medicine Program (RMP) in the Rady Faculty of Health Sciences at the University of Manitoba in Winnipeg. http://umanitoba.ca/healthsciences/, http://home.cc.umanitoba.ca/~karimis/
How to apply
Interested candidates should send their CV, a brief statement of research interests and contact information for 3 references to Dr. Soheila Karimi at Soheila.Karimi@umanitoba.ca.